{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T10:34:44Z","timestamp":1758191684742,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":233,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.rmcr.2025.102278","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T14:59:38Z","timestamp":1756565978000},"page":"102278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Scedosporium infection as a late complication after start of elexacaftor\/tezacaftor\/ivacaftor: two case reports"],"prefix":"10.1016","volume":"57","author":[{"given":"P","family":"van Mourik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.C.","family":"van der Hout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.D.","family":"Luijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.W.","family":"Hofland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.H.W.","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.G.M.","family":"Heijerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Bronsveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.rmcr.2025.102278_bib1","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"10212","key":"10.1016\/j.rmcr.2025.102278_bib2","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.rmcr.2025.102278_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167957","article-title":"Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist","volume":"133","author":"Nichols","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.rmcr.2025.102278_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107406","article-title":"Long-term clinical outcomes of elexacaftor\/tezacaftor\/ivacaftor therapy in adults with cystic fibrosis and advanced pulmonary disease","volume":"219","author":"Savi","year":"2023","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.rmcr.2025.102278_bib5","article-title":"Review of the novel investigational antifungal olorofim","volume":"6","author":"Wiederhold","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"6","key":"10.1016\/j.rmcr.2025.102278_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myad051","article-title":"Outcome of patients with cystic fibrosis colonized by Scedosporium and Lomentospora species: a longitudinal cohort study","volume":"61","author":"Parize","year":"2023","journal-title":"Med. Mycol."},{"issue":"162","key":"10.1016\/j.rmcr.2025.102278_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0103-2021","article-title":"Aspergillus-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease?","volume":"30","author":"Lv","year":"2021","journal-title":"Eur. Respir. Rev."},{"issue":"2","key":"10.1016\/j.rmcr.2025.102278_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jcf.2018.08.012","article-title":"Combined antifungal therapy is superior to monotherapy in pulmonary scedosporiosis in cystic fibrosis","volume":"18","author":"Schwarz","year":"2019","journal-title":"J. Cyst. Fibros."},{"issue":"3","key":"10.1016\/j.rmcr.2025.102278_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myae020","article-title":"Evaluation of the drug\u2013drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort","volume":"62","author":"Jansen","year":"2024","journal-title":"Med. Mycol."},{"key":"10.1016\/j.rmcr.2025.102278_bib10","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.5931","article-title":"Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis","volume":"6","author":"Zhao","year":"2018","journal-title":"PeerJ"}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007125001145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007125001145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:46:28Z","timestamp":1758127588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007125001145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":10,"alternative-id":["S2213007125001145"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2025.102278","relation":{},"ISSN":["2213-0071"],"issn-type":[{"type":"print","value":"2213-0071"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scedosporium infection as a late complication after start of elexacaftor\/tezacaftor\/ivacaftor: two case reports","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2025.102278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102278"}}